FOR IMMEDIATE RELEASE
Dr. Janice B. Schwartz to Receive William B. Abrams Award for Geriatric Clinical Pharmacology
Alexandria, VA (December 15, 2011) — Janice B. Schwartz, MD, is the 2012 recipient of the American Society for Clinical Pharmacology and Therapeutics (ASCPT) William B. Abrams Award for Geriatric Clinical Pharmacology.
The William B. Abrams Award for Geriatric Clinical Pharmacology recognizes scientists who have made remarkable contributions to the field of geriatric clinical pharmacology. Established in 1996 with support from the Merck Company Foundation, the award honors William B. Abrams, MD. Dr. Abrams was president of ASCPT from 1975 to 1976 and led an eminent career in the pharmaceutical industry, primarily at Merck Research Laboratories. Among his many accomplishments, Dr. Abrams worked at the FDA as the first special government employee to help establish the Center for Drug Evaluation and Research Staff College.
ASCPT will present the award to Dr. Schwartz on March 14, 2012, prior to the opening session of the 113th Annual Meeting at the National Harbor in Maryland.
Dr. Schwartz is a clinical professor of Medicine and Bioengineering and Therapeutic Sciences at the University of California, San Francisco (UCSF), and Director of Research for the Jewish Home of San Francisco. Prior to returning to UCSF in 2000, she was Chief of Clinical Pharmacology and Geriatric Medicine at Northwestern University Medical School. She was an editorial board member for the American Journal of Geriatric Cardiology, Clinical Pharmacology and Therapeutics, and Journal of the American Geriatric Society. She has also served on numerous NIH study sections and is currently a member of the NIH Aging Systems and Geriatrics Study Section.
Dr. Schwartz is a past recipient of the Pharmaceutical Research and Manufacturers of America Foundation Faculty Development Award in Clinical Pharmacology. She is a member of the American Geriatric Society, of the American Heart Association, and a Fellow of the American College of Cardiology. Dr. Schwartz has chaired the ASCPT Scientific Section on Geriatric Clinical Pharmacology and served on the Board of Directors. Her research has attempted to understand why and when the effects of pharmacological agents are different in older individuals compared to younger individuals. In her research on pharmacological effects in the elderly, Dr. Schwartz has pursued both laboratory investigations and led many clinical studies. Her findings have been recognized by some of the most prominent geriatric clinical pharmacology journals and have elucidated differences between the sexes at older ages and changed concepts regarding age-related changes in medication metabolism in the elderly.
ASCPT is the leading forum for the discussion, development, and integration of clinical pharmacology in the drug development continuum—from discovery to safe and effective use. Headquartered in Alexandria, Virginia, ASCPT was established in 1900. Today, more than 2,100 ASCPT members are committed to advancing the science of human pharmacology and therapeutics worldwide.
Sharon Swan, CAE